Another topic that has sparked public debate is the exorbitant cost of CAR-T therapy.
CAR-T cell therapy involves extracting a patient's own T cells, using gene engineering technology to introduce chimeric antigen receptors (CARs) into the T cells, and then reinfusing them into the patient's body. The entire process, apart from being complex, is personalized and customized, making mass production like conventional drugs and biologics impossible, thus resulting in high costs.
According to 39 Health, the current price abroad is around 2.4 million RMB per dose, and the domestic price is around 1.2 million RMB per dose. CAR-T therapy has not yet been included in the latest National Medical Insurance Directory.
